ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention

ED to EPI: Using SMS (Text) Messaging to Improve the Transition From the Emergency Department to Early Psychosis Intervention for Young People With Psychosis

Psychosis is a disabling condition that typically has its onset in adolescence and early adulthood. Many young people with psychosis have difficulty navigating services or are reluctant to engage in treatment until their illness becomes an emergency. Consequently, nearly half of all new psychotic disorders are diagnosed in the emergency department (ED). Despite the rationale and evidence for early psychosis intervention (EPI), around half of youth do not access these services. The investigators will use short message service (SMS)/text messaging, a low-cost, low-complexity, youth-friendly approach, to improve transitions in care from the ED and related acute services to EPI services, investigating the intervention's effect on attendance at the first consultation appointment, longer term service engagement, and system-level outcomes. The investigators will also evaluate cost-effectiveness and user perspectives of the intervention.

Study Overview

• Status: Recruiting
• Conditions: Schizophrenia; Schizophrenia Spectrum and Other Psychotic Disorders; Schizoaffective Disorder; Bipolar Disorder; Psychosis; Schizophreniform Disorders; Substance Induced Psychoses; Psychotic Episode; First Episode Psychosis; Psychoses, Affective; Depressive Psychosis
• Intervention / Treatment: Behavioral: Active SMS Intervention; Behavioral: Sham SMS

Detailed Description

At the Centre for Addiction and Mental Health (CAMH), the investigators will recruit a consecutive series of 186 participants aged 16 to 29 referred by the CAMH ED and related acute services to CAMH's EPI program for a pragmatic randomized controlled trial of a 2-way SMS intervention involving reminders, psychoeducation, and check-ins. The primary outcome will be rate of attendance at the first consultation appointment assessed through chart reviews. Secondary outcomes will include indicators of long-term service engagement as well as symptoms and functioning 6 months following study enrollment and health service utilization for up to 2 years using administrative data from the Institute for Clinical Evaluative Sciences (ICES). Administrative data will be used for an economic analysis. Participants who receive the active intervention will be asked to complete a web-based survey evaluating their experience and a subgroup will be asked to participate in in-depth in-person qualitative interviews. Patients and family members with lived experience will be engaged in all aspects of the project, including shaping the intervention and study design.

The investigators hypothesize that the intervention will result in increased rate of attendance at the first EPI consultation appointment, as well as improved longer-term engagement in outpatient EPI services compared to the sham comparator. Demonstrating evidence that this low-cost, low-complexity, youth-friendly intervention improves engagement in outpatient EPI services has the potential to improve long-term outcomes for young people with psychosis.

• Study Type: Interventional
• Enrollment (Estimated): 186
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Nicole Kozloff, MD, SM; Phone Number: 30769 4165358501; Email: n.kozloff@mail.utoronto.ca

Study Locations

• Canada
  • Ontario
    • Toronto, Ontario, Canada, M6J1H1
      • Recruiting
      • Centre for Addiction and Mental Health
      • Contact: Nicole Kozloff, MD, SM; Phone Number: 30769 4165358501; Email: nicole.kozloff@camh.ca

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years to 27 years (Child, Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Have been referred by the Centre for Addiction and Mental Health (CAMH) emergency department or related acute services to the CAMH early psychosis intervention (EPI) program for suspected psychosis

Exclusion Criteria:

• Inability to communicate in basic written English

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Active SMS Intervention; Participants assigned to the experimental arm will receive the active SMS intervention. Participants in the active intervention group who consent to participate will be asked to complete a web-based survey. Based on survey findings, purposive sampling will be used to select a subsample of 12 to 20 participants for qualitative interviews.	Behavioral: Active SMS Intervention; Welcome message letting participant know they will be contacted to book an appointment, followed by appointment reminders and other clinic information, psychoeducational materials, and a distress check-in with two-way feedback to their care team, all sent by SMS/text message at the participant's preferred time of day. If they indicate that they are in high distress, or they request, their care provider will be notified and asked to reach out to them. They will also receive crisis resources.The intervention will continue until the patient attends the first consultation appointment, or for up to 30 days if the patient does not attend, which reflects the program's practice of closing referrals for non-attending patients.
Sham Comparator: Sham SMS; Participants assigned to the sham comparator will receive the sham SMS intervention. They will not be re-contacted.	Behavioral: Sham SMS; Single welcome message letting participant know they will be contacted to book an appointment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Attendance at the first early psychosis intervention (EPI) consultation appointment	Attendance at the outpatient EPI consultation appointment will be assessed through chart reviews and categorized as: Yes - attended at original appointment time, Yes - attended at later date within 30 days, No - did not attend appointment within 30 days.	30 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Service engagement - absolute drop-out	Absolute dropouts will be assessed through chart reviews and categorized as: Still in EPI treatment, Not accepted for EPI treatment, Accepted for EPI treatment but transitioned to local services, Accepted for EPI treatment but disengaged, or Other.	6 months
Service engagement - Service Engagement Scale (SES)	The Service Engagement Scale is a brief, validated, clinician-rated tool designed to measure engagement with community mental health services. In 14 items, it assesses patients' availability for treatment, collaboration, help seeking behaviors and treatment adherence on a four-point Likert scale with total scores ranging from 0-42, and higher scores indicating difficulties in service engagement. The Service Engagement Scale total score and treatment adherence score will be extracted through chart reviews.	6 months
Change in psychotic illness as measured by the Clinical Global Impression (CGI)	The Clinical Global Impression (CGI) is a clinician-rated measure of the patient's symptom severity and treatment response prior to and after initiating an intervention. It includes subscales for Severity and Improvement. The Clinical Global Impression - Severity scale ranges from 1-7 with higher scores indicating higher severity of illness, relative to other patients with the same diagnosis. The Clinical Global Impression - Improvement scale ranges from 1-7 with 4 indicating no change, 1 indicating very much improved, and 7 indicating very much worse relative to the patient's illness at the beginning of the intervention. Scores will be extracted through chart reviews.	6 months
System-level outcomes: emergency department visits	Number of emergency department visits, extracted from provincial administrative data held at the Institute for Clinical Evaluative Sciences (ICES)	6 months and 2 years
System-level outcomes: mental health hospitalizations	Number of mental health hospitalizations, extracted from provincial administrative data held at the Institute for Clinical Evaluative Sciences (ICES)	6 months and 2 years
System-level outcomes: days in mental health hospitalizations	Number of days in mental health hospitalizations, extracted from provincial administrative data held at the Institute for Clinical Evaluative Sciences (ICES)	6 months and 2 years
System-level outcomes: outpatient mental health visits with primary care provider	Number of outpatient mental health visits with primary care provider, extracted from provincial administrative data held at the Institute for Clinical Evaluative Sciences (ICES)	6 months and 2 years
System-level outcomes: outpatient mental health visits with psychiatrist	Number of outpatient mental health visits with psychiatrist, extracted from provincial administrative data held at the Institute for Clinical Evaluative Sciences (ICES)	6 months and 2 years
System-level outcomes: continuous prescriptions	For participants with provincial drug coverage, continuous vs. non-continuous prescriptions for antipsychotic or mood stabilizer medications, extracted from provincial administrative data held at the Institute for Clinical Evaluative Sciences (ICES)	6 months and 2 years
System-level outcomes: mortality	Mortality, extracted from provincial administrative data held at the Institute for Clinical Evaluative Sciences (ICES)	6 months and 2 years
Health care costs	Total direct patient-level health care costs incurred by the public third-party payer based on administrative data held at the Institute for Clinical Evaluative Sciences (ICES) using an established costing algorithm	6 months and 2 years

Collaborators and Investigators

• Sponsor: Centre for Addiction and Mental Health
• Collaborators: Canadian Institutes of Health Research (CIHR); Institute for Clinical Evaluative Sciences
• Investigators: Principal Investigator: George Foussias, MD, PhD, Centre for Addiction and Mental Health; Principal Investigator: Aristotle N Voineskos, MD, PhD, Centre for Addiction and Mental Health; Principal Investigator: Vicky Stergiopoulos, MD, MHSc, Centre for Addiction and Mental Health; Principal Investigator: Albert HC Wong, MD, PhD, Centre for Addiction and Mental Health; Principal Investigator: Nicole Kozloff, MD, SM, Centre for Addiction and Mental Health

Publications and helpful links

General Publications

• Polillo A, Foussias G, Wong AHC, Ampofo A, Stergiopoulos V, Anderson KK, Bromley S, D'Arcey J, de Oliveira C, Duda L, Henderson J, Kidd S, Kurdyak P, Wang W, Zaheer J, Voineskos AN, Kozloff N. ED to EPI: protocol for a pragmatic randomised controlled trial of an SMS (text) messaging intervention to improve the transition from the emergency department to early psychosis intervention for young people with psychosis. BMJ Open. 2020 Dec 17;10(12):e042751. doi: 10.1136/bmjopen-2020-042751.

Study record dates

Study Major Dates

• Study Start (Actual): September 21, 2020
• Primary Completion (Estimated): December 1, 2024
• Study Completion (Estimated): December 1, 2025

Study Registration Dates

• First Submitted: March 3, 2020
• First Submitted That Met QC Criteria: March 4, 2020
• First Posted (Actual): March 6, 2020

Study Record Updates

• Last Update Posted (Actual): March 18, 2024
• Last Update Submitted That Met QC Criteria: March 15, 2024
• Last Verified: March 1, 2024

More Information

Terms related to this study

• Keywords: Pragmatic Clinical Trials; Early Psychosis Intervention; Mobile Health Intervention; Patient and Family Engagement; Transitions in Care
• Additional Relevant MeSH Terms: Chemically-Induced Disorders; Pathologic Processes; Substance-Related Disorders; Mood Disorders; Disease Attributes; Bipolar and Related Disorders; Poisoning; Emergencies; Schizophrenia; Psychotic Disorders; Mental Disorders; Bipolar Disorder; Shared Paranoid Disorder; Schizophrenia Spectrum and Other Psychotic Disorders; Psychoses, Substance-Induced; Affective Disorders, Psychotic
• Other Study ID Numbers: 088/2019

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: De-identified individual patient data (IPD) other than system-level data held at ICES will be available upon reasonable request.
• IPD Sharing Time Frame: Within 12 months of posting the study results on this website
• IPD Sharing Access Criteria: Access is provided after a research proposal is submitted and has received approval from the study's Steering Committee and after Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension can be granted, when justified, for up to another 12 months.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; SAP; ICF

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No